Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 12, 2016 | ApoGen Biotechnologies | $7.0M Series A | — | AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Johnson & Johnson Innovation, Watson Fund, WRF Capital, WuXi AppTec |